{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T20:55:07Z","timestamp":1761339307738},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.jviromet.2013.03.021","type":"journal-article","created":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T19:12:15Z","timestamp":1366139535000},"page":"82-87","source":"Crossref","is-referenced-by-count":3,"title":["Comparative evaluation of the Abbott HIV-1 RealTime\u2122 assay with the Standard Roche COBAS\u00ae Amplicor\u2122 HIV-1 Monitor\u00ae Test, v1.5 for determining HIV-1 RNA levels in plasma specimens from Pune, India"],"prefix":"10.1016","volume":"191","author":[{"given":"Priyanka","family":"Khopkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Mallav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shweta","family":"Chidrawar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smita","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2013.03.021_bib0005","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4103\/0971-5916.92628","article-title":"Low-cost assays for monitoring HIV infected individuals in resource-limited settings","volume":"134","author":"Balakrishnan","year":"2011","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1191\/096228099673819272","article-title":"Measuring agreement in method comparison studies","volume":"8","author":"Bland","year":"1999","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1515\/CCLM.2007.008","article-title":"Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine","volume":"45","author":"Braun","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1086\/510073","article-title":"HIV viral load monitoring in resource-limited regions: optional or necessary?","volume":"44","author":"Calmy","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0025","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1128\/JCM.02595-10","article-title":"Evaluation of the Abbott RealTime CT\/NG assay in comparison to the Roche Cobas Amplicor CT\/NG assay","volume":"49","author":"Cheng","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0030","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1128\/JCM.02046-07","article-title":"Evaluation of the Abbott RealTime HBV DNA assay and comparison to the Cobas AmpliPrep\/Cobas TaqMan 48 assay in monitoring patients with chronic cases of hepatitis B","volume":"46","author":"Ciotti","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0035","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"Cohen","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0040","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1128\/JCM.00973-07","article-title":"Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep\/COBAS TaqMan HIV-1 assays","volume":"45","author":"Damond","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0045","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1371\/journal.pmed.0030417","article-title":"HIV-1 viral load assays for resource-limited settings","volume":"3","author":"Fiscus","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0050","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/510752","article-title":"Drug resistance after failure of initial antiretroviral therapy in resource-limited countries","volume":"44","author":"Gallant","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0055","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/JCM.44.5.1788-1791.2006","article-title":"Comparative evaluation of the performance of the Abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for measurement of HIV-1 plasma viral load following automated specimen preparation","volume":"44","author":"Garcia-Diaz","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0060","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1128\/JCM.01019-10","article-title":"Performance of the Abbott RealTime CT\/NG for detection of Chlamydia trachomatis and Neisseria gonorrhoeae","volume":"48","author":"Gaydos","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0065","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1097\/00002030-200311070-00009","article-title":"Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine","volume":"17","author":"Gulick","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2013.03.021_bib0070","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1086\/590943","article-title":"Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials","volume":"47","author":"Gupta","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0075","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcv.2010.05.008","article-title":"Evaluation of the clinical performance of the Abbott RealTime High-Risk HPV for carcinogenic HPV detection","volume":"48","author":"Halfon","year":"2010","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0080","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1128\/JCM.00163-06","article-title":"Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection","volume":"44","author":"Halfon","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0085","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1056\/NEJMe1107487","article-title":"Antiretroviral treatment as prevention","volume":"365","author":"Hammer","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.jviromet.2013.03.021_bib0090","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S1386-6532(09)70003-4","article-title":"Principles and analytical performance of Abbott RealTime High Risk HPV test","volume":"45","author":"Huang","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0095","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1128\/JCM.00578-12","article-title":"Cross-platform analysis of HIV-1 RNA data generated by a multicenter assay validation study with wide geographic representation","volume":"50","author":"Jennings","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0100","series-title":"Conference on Retroviruses and Opportunistic Infections","article-title":"PHPT-3: a randomized clinical trial comparing CD4 vs viral load ART monitoring\/switching strategies in Thailand","author":"Jourdain","year":"2011"},{"key":"10.1016\/j.jviromet.2013.03.021_bib0105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/0255-0857.42031","article-title":"Evidence for lower CD4+ T cell and higher viral load in asymptomatic HIV-1 infected individuals of India: implications for therapy initiation","volume":"26","author":"Kannangai","year":"2008","journal-title":"Indian J. Med. Microbiol."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0110","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/QAI.0b013e318074ef6e","article-title":"The relation between symptoms, viral load, and viral load set point in primary HIV infection","volume":"45","author":"Kelley","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jviromet.2011.04.006","article-title":"Comparison of the Abbott RealTime High Risk HPV test and INNO-LiPA HPV Genotyping Extra test for the detection of human papillomaviruses in formalin-fixed, paraffin-embedded cervical cancer specimens","volume":"175","author":"Kocjan","year":"2011","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2013.03.021_bib0120","series-title":"Conf. on Retroviruses and Opportunistic Infections, vol. 11","first-page":"825","article-title":"Monitoring of HIV viral load, CD4 cell count, and clinical monitoring versus clinical monitoring alone for antiretroviral therapy in rural hospitals in Cameroon: Startall ANRS 12110\/ESTHER trial, a randomized non-inferiority trial","author":"Kouanfack","year":"2011"},{"key":"10.1016\/j.jviromet.2013.03.021_bib0125","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1371\/journal.ppat.0030046","article-title":"ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia","volume":"3","author":"Maldarelli","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0130","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/JCM.01956-06","article-title":"Characteristics of the m2000 automated sample preparation and multiplex real-time PCR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae","volume":"45","author":"Marshall","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0135","unstructured":"NACO, 2007. National AIDS Control Organization \u2013 Guidelines for HIV Testing, March 2007. DR-ART Failure and Therapy, India."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0140","unstructured":"OARAC, 2009. DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents \u2013 A Working Group of the Office of AIDS Research Advisory Council (OARAC). Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0145","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1128\/JCM.00221-07","article-title":"Comparative evaluation of the automated Roche TaqMan real-time quantitative human immunodeficiency virus type 1 RNA PCR assay and the Roche AMPLICOR Version 1.5 conventional PCR assay","volume":"45","author":"Oliver","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0150","first-page":"539","article-title":"CD4+ T cell count as a tool to monitor HIV progression & anti-retroviral therapy","volume":"121","author":"Pattanapanyasat","year":"2005","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/108729104322802506","article-title":"Molecular-based methods for quantifying HIV viral load","volume":"18","author":"Peter","year":"2004","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.jviromet.2013.03.021_bib0160","doi-asserted-by":"crossref","first-page":"835","DOI":"10.4103\/0971-5916.92629","article-title":"Optimizing adherence to antiretroviral therapy","volume":"134","author":"Sahay","year":"2011","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jcv.2007.07.013","article-title":"Evaluation of the analytical performance of the new Abbott RealTime RT-PCRs for the quantitative detection of HCV and HIV-1 RNA","volume":"40","author":"Schutten","year":"2007","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0170","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jviromet.2007.06.019","article-title":"Evaluation of two commercially available alternatives for HIV-1 viral load testing in resource-limited settings","volume":"146","author":"Steegen","year":"2007","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2013.03.021_bib0175","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1128\/JCM.43.2.857-861.2005","article-title":"Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa","volume":"43","author":"Stevens","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0180","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/JCM.01540-06","article-title":"Evaluation of the performance of the automated NucliSENS easyMAG and EasyQ systems versus the Roche AmpliPrep-AMPLICOR combination for high-throughput monitoring of human immunodeficiency virus load","volume":"45","author":"Stevens","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0185","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jviromet.2006.06.010","article-title":"Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from London: comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx HIV RNA Quantitative assays","volume":"137","author":"Swanson","year":"2006","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2013.03.021_bib0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jviromet.2006.11.026","article-title":"Evaluation of performance across the dynamic range of the Abbott RealTime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses","volume":"141","author":"Swanson","year":"2007","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2013.03.021_bib0195","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jviromet.2006.01.012","article-title":"Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from Brazil","volume":"134","author":"Swanson","year":"2006","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2013.03.021_bib0200","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jviromet.2007.07.003","article-title":"A RealTime HIV-1 viral load assay for automated quantitation of HIV-1 RNA in genetically diverse group M subtypes A-H, group O and group N samples","volume":"146","author":"Tang","year":"2007","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2013.03.021_bib0205","unstructured":"UNAIDS, 2010. Global Report: UNAIDS Report on Global AIDS Epidemic 2010."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0210","unstructured":"UNGASS, 2010. India \u2013 Country Progress Report."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0215","doi-asserted-by":"crossref","first-page":"801","DOI":"10.4103\/0971-5916.92627","article-title":"Current practices in laboratory monitoring of HIV infection","volume":"134","author":"Vajpayee","year":"2011","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0220","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jcv.2011.10.016","article-title":"Comparison of Abbott RealTime High Risk HPV and Hybrid Capture 2 for the detection of high-risk HPV DNA in a referral population setting","volume":"53","author":"Venturoli","year":"2012","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0225","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3851\/IMP1411","article-title":"Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south India","volume":"14","author":"Vidya","year":"2009","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0230","unstructured":"VQA, 2010. Virology Quality Assurance, HIV RNA Proficiency Testing Program. Validation Plan for Verification of Performance Specifications for an Unmodified FDA-approved Assay, pp. 1\u20136."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0235","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.biotechadv.2010.06.004","article-title":"Advances in developing HIV-1 viral load assays for resource-limited settings","volume":"28","author":"Wang","year":"2010","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0240","unstructured":"WHO, 2009. World Health Organization Rapid Advice: Antiretroviral Therapy for HIV Infection in Adults and Adolescents."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0245","unstructured":"WHO, 2010. World Health Organization \u2013 HIV\/AIDS in the South East Asia Region: Progress Report, 2010."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0250","unstructured":"WHO, 2010. World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents. Recommendations for a Public Health Approach: 2010 Revision."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0255","series-title":"Global Health Sector Strategy on HIV\/AIDS 2011\u20132015","author":"WHO","year":"2011"},{"key":"10.1016\/j.jviromet.2013.03.021_bib0260","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1586\/14737159.7.3.237","article-title":"Molecular assays for monitoring HIV infection and antiretroviral therapy","volume":"7","author":"Wittek","year":"2007","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0265","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1515\/CCLM.2007.149","article-title":"Comparison of the Roche COBAS Amplicor Monitor, Roche COBAS Ampliprep\/COBAS Taqman and Abbott RealTime Test assays for quantification of hepatitis C virus and HIV RNA","volume":"45","author":"Wolff","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0270","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jcv.2011.03.010","article-title":"Efficacy of Abbott RealTime High Risk HPV test in evaluation of atypical squamous cells of undetermined significance from an Asian screening population","volume":"51","author":"Wong","year":"2011","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2013.03.021_bib0275","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcv.2008.01.009","article-title":"Performance of the Abbott RealTime HIV-1 assay for quantification of HIV-1 clades prevalent in China","volume":"41","author":"Xu","year":"2008","journal-title":"J. Clin. Virol."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093413000979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093413000979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T20:20:08Z","timestamp":1539721208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093413000979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0166093413000979"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2013.03.021","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}